Table 7. Mouse PK Properties of Compounds 24f, 25a, and TCA1.
24f |
25a |
TCA1 |
|||||
---|---|---|---|---|---|---|---|
parameters | units | p.o. | i.v. | p.o. | i.v. | p.o. | i.v. |
dose | mg/kg | 50 | 5 | 50 | 5 | 50 | 5 |
t1/2a | h | 1.70 | 0.13 | 0.85 | 0.26 | 2.19 | 0.47 |
tmax | h | 1.00 | 0.58 | 1.00 | |||
Cmax | ng/mL | 25.4 | 1299 | 486 | 4555 | 10 603 | 14 304 |
AUC0–t | ng·h/mL | 41.9 | 183 | 651 | 830 | 33 715 | 7910 |
AUC0–∞b | ng·h/mL | 57.9 | 184 | 657 | 833 | 33 724 | 7912 |
MRT0–∞c | h | 2.10 | 0.13 | 1.10 | 0.20 | 2.87 | 0.39 |
clearance | mL/(min·kg) | 479 | 101 | 10.6 | |||
Fd | % | 2.3 | 7.9 | 42.6 |
Plasma elimination half-life.
Plasma exposure.
Mean residence time.
Oral bioavailability.